← Leaderboards
Cristina Backman
National Institute On Drug Abuse
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute On Drug Abuse
Same institution · by research overlap
Others in their field
Top investigators on “Dopaminergic Neuron”
- Daniel M Corcos · Northwestern University$25,533,481
- Dalton James Surmeier · University Of Tennessee Health Sci Ctr$23,381,710
- Jie Shen · Brigham And Women'S Hospital$19,419,035
- Naoshige Uchida · Harvard University$16,492,122
- Krystof S Bankiewicz · Ohio State University$15,709,231
- William Richard Stauffer · University Of Pittsburgh At Pittsburgh$14,604,112
Research focus
Dopaminergic NeuronDopamineBrainNeuronsMediatingGenesResponseAdultSubstantia Nigra StructureAblationAffectPathway InteractionsVentral Tegmental AreaAreaBehavioralCorpus Striatum StructureAnimalsMutationLaboratoriesMidbrain StructureCellsRecombinaseDopamine TransporterNull Mutation
Grant awards (24)
Genetically mofidied stem cells: Can we improve stem cell replacement therapies?$428,368
ZIA · FY2012 · DA · contact PI
Cre recombinase mediated deletion of BDNF in dopamine neurons$285,579
ZIA · FY2012 · DA · contact PI
Effects of a null mutation of the gene beta catenin in dopamine neurons$142,789
ZIA · FY2012 · DA · contact PI
Cre recombinase mediated deletion of BDNF in dopamine neurons$854,480
ZIA · FY2011 · DA · contact PI
Genetically mofidied stem cells: Can we improve stem cell replacement therapies?$671,200
ZIA · FY2011 · DA · contact PI
Effects of a null mutation of the gene beta catenin in dopamine neurons$569,653
ZIA · FY2011 · DA · contact PI
Genetically mofidied stem cells: Can we improve stem cell replacement therapies?$798,525
ZIA · FY2010 · DA · contact PI
Effects of a null mutation of the tumor suppressor gene PTEN in dopamine neurons$598,893
ZIA · FY2010 · DA · contact PI
Cre recombinase mediated deletion of the NMDA receptor in dopamine neurons$452,052
ZIA · FY2010 · DA · contact PI
Cre recombinase mediated deletion of BDNF in dopamine neurons$376,710
ZIA · FY2010 · DA · contact PI
Effects of a null mutation of the gene beta catenin in dopamine neurons$376,710
ZIA · FY2010 · DA · contact PI
Genetically mofidied stem cells: Can we improve stem cell replacement therapies?$556,475
ZIA · FY2009 · DA · contact PI
Cre recombinase mediated deletion of the NMDA receptor in dopamine neurons$417,356
ZIA · FY2009 · DA · contact PI
Effects of a null mutation of the tumor suppressor gene PTEN in dopamine neurons$389,532
ZIA · FY2009 · DA · contact PI
DK, D1K and D2K: CREB and drug addiction$699,917
Z01 · FY2008 · DA · contact PI
Effects of a null mutation of the tumor suppressor gene PTEN in dopamine neurons$450,577
Z01 · FY2008 · DA · contact PI
DK, D1K and D2K: CREB and drug addiction$494,841
Z01 · FY2007 · DA · contact PI
Effects of a null mutation of the tumor suppressor gene PTEN in dopamine neurons$454,848
Z01 · FY2007 · DA · contact PI
DK, D1K and D2K: CREB and drug addiction$0
Z01 · FY2006 · DA · contact PI
TC Knock-in: A Molecular Map of the Mesolimbic Dopaminer$0
Z01 · FY2006 · DA · contact PI
TC Knock-in:Molecular Map-Mesolimbic Dopaminergic System$0
Z01 · FY2005 · DA
DK, D1K and D2K: CREB and drug addiction$0
Z01 · FY2005 · DA
BAC Transgenic Mice Encoding Tau Green Through the Nurr1$0
Z01 · FY2004 · DA
siRNAs for Reducing Phenotypic Markers /Studying Gene Fu$0
Z01 · FY2004 · DA